July 21, 2009 – Sandoz launches Zarzio(filgrastim), a recombinant granulocyte colony-stimulating factor (G-CSF) for the treatment of neutropenia (low white blood cell count) associated with chemotherapy treatment or advanced HIV infection and the mobilisation of peripheral blood progenitor cells1.
The details can be read here.
No comments:
Post a Comment